Home Stock

Stock Research: DiaSorin

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

DiaSorin

MIL:DIA IT0003492391
19
  • Value
    78
  • Growth
    13
  • Safety
    Safety
    74
  • Combined
    46
  • Sentiment
    3
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DiaSorin SpA develops, produces, and commercializes reagent kits for in vitro diagnostics. The company operates in the healthcare industry, specializing in infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company operates in the Immunodiagnostics and Molecular Diagnostics markets. In the last fiscal year, the company had a market cap of $5,841 million, profits of $809 million, revenue of $1,227 million, and 3271 employees.

more

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock DiaSorin are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for DiaSorin. The consolidated Value Rank has an attractive rank of 78, which means that the share price of DiaSorin is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 78% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 74. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 3. Professional investors are more confident in 97% other stocks. The consolidated Growth Rank also has a low rank of 13, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 87 of its competitors have better growth. ...read more

more
Strongest Rank Sentiment
Weakest Rank Refinancing
Country Italy
Industry Health Care Equipment
Size Large
Website int.diasorin.com
Index
MIB
DiaSorin stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
78 32 23 34
Growth
13 88 21 7
Safety
Safety
74 48 50 98
Sentiment
3 60 10 90
360° View
360° View
19 80 6 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
9 13 13 19
Opinions Change
33 50 10 64
Pro Holdings
n/a 73 31 90
Market Pulse
27 75 65 89
Sentiment
3 60 10 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
78 32 23 34
Growth
13 88 21 7
Safety Safety
74 48 50 98
Combined
46 75 6 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
61 26 27 27
Price vs. Earnings (P/E)
46 34 33 31
Price vs. Book (P/B)
67 40 37 37
Dividend Yield
75 47 39 37
Value
78 32 23 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
32 73 12 12
Profit Growth
67 83 12 54
Capital Growth
18 76 100 27
Stock Returns
10 56 18 32
Growth
13 88 21 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
47 20 22 92
Refinancing
88 53 59 71
Liquidity
64 61 53 92
Safety Safety
74 48 50 98

Similar Stocks

Discover high‑ranked alternatives to DiaSorin and broaden your portfolio horizons.

Philips

AEX:PHIA
Country: Netherlands
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Italmobiliare

MIL:ITM
Country: Italy
Industry: Industrial Conglomerates
Size: Medium
Full Stock Analysis

Azimut

MIL:AZM
Country: Italy
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews